• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Nektar Therapeutics

edit

Nektar Therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. Nektar also partners with the top biopharmaceutical companies to bring new products to market. To date, Nektar’s technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

Milestones

edit

• 
  Nektar Therapeutics added Bharatt Chowrira as Chief Operating Officer.
  Posted 6/26/09 at 5:28am
• 
  Nektar Therapeutics added Howard W. Robin as President and Chief Executive Officer.
  Posted 6/26/09 at 5:28am
• 
  Nektar Therapeutics invested in Pearl Therapeutics. (7/3/08)
  Posted 6/26/09 at 5:10am via venturebeat.com

Videos

Screenshots

edit

Above: Nektar Therapeutics
Uploaded: 6/26/09

Sources

1. Pearl Therapeutics ups its first round funding (deals.venturebeat.com) [edit]